Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 8, 2013-10 ,pp. : 719-726

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel IRAK-4 Inhibitors Through Pharmacophore Modeling, Atom-based 3D-QSAR, Docking Strategies and Molecular Dynamics Simulation

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 879-887

Bentham Science Publishers

Access to resources Recommend Favorite

In silico Studies Toward the Discovery of Novel Type-II Inhibitors of TrkA: Pharmacophore-based 3D-QSAR Modeling, Database Screening and Molecular Docking

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 6, 2016-06 ,pp. : 526-538

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Modeling, 3D-QSAR and Molecular Docking of Furanochalcones as Inhibitors of Monoamine Oxidase-B

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 16, Iss. 2, 2016-08 ,pp. : 105-111

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 7, 2016-08 ,pp. : 577-586

Bentham Science Publishers

Access to resources Recommend Favorite